ENANTA PHARMACEUTICALS INC (ENTA) Form 8-K — Oct 28, 2026
$ENTAForm 8-KItems 5.02, 7.01, 9.01Filed Oct 28, 2026, 7:14 AM ET0001193125-26-435092Original filing
Enanta Pharmaceuticals announced that Jay R. Luly, Ph.D., age 70, will retire as President and CEO by February 1, 2027 after 23 years leading the company. He will remain as a strategic advisor through the remainder of 2027 to support the transition. The Board has initiated a comprehensive search for a successor, considering both internal and external candidates.
Key figures
- Ceo age
- 70
- Advisor through
- remainder of 2027
- Ceo tenure years
- 23
- Retirement deadline
- 2027-02-01
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.